Insulin resistance - when the body doesn't properly respond to insulin, a hormone that helps control blood glucose levels - ...

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue financial results for the fourth quarter and full year ...

AI in Pathology Market OverviewThe global AI in pathology market is anticipated to witness robust expansion, growing at an estimated compound annual growth rate of around 26% during the forecast ...

CCNSB researchers at IIIT Hyderabad focus on genomics, epigenetics and AI for cancer detection and treatment: Our Bureau, Bengaluru Monday, February 16, 2026, 15:50 Hrs [IST] Rese ...

The study also highlights the limitations of relying on body mass index (BMI) as a proxy for metabolic health.

Cancer cannot be explained by mutations alone. Today, cancer is understood as a multifactorial disease, shaped by genetics, ...

Cancer is no longer seen as a single genetic error but as a complex, multi-layered disease shaped by DNA mutations, epigenetic changes and even patterns in medical images. New research at ...

Hyderabad are advancing cancer research by integrating genomics, epigenetics, gene regulation and artificial intelligence to ...

Insulin resistance—when the body doesn't properly respond to insulin, a hormone that helps control blood glucose levels—is ...

Study identified numerous influential “hub genes” that offer promising new targets for early detection and therapeutic intervention.

An AI-led study in The BMJ flags nearly 10 per cent of global cancer research papers as potentially fake, raising alarms about paper mills and the integrity of cancer science worldwide ...

A large-scale analysis of millions of cancer studies has uncovered patterns suggesting that a significant portion of the literature may not be as reliable as it appears.